These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 14625878)

  • 21. CCK-4-induced anxiety but not panic is associated with serum brain-derived neurotrophic factor in healthy subjects.
    Maron E; Tõru I; Mäemets K; Sepp S; Vasar V; Shlik J; Zharkovsky A
    J Psychopharmacol; 2009 Jun; 23(4):460-4. PubMed ID: 18562429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma gamma-amino-butyric acid (GABA) levels in cholecystokinine-tetrapeptide (CCK-4) induced anxiety.
    Zwanzger P; Jarry H; Eser D; Padberg F; Baghai T; Schule C; Ella R; Möller HJ; Rupprecht R
    J Neural Transm (Vienna); 2003 Mar; 110(3):313-6. PubMed ID: 12658378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of CI-988 on cholecystokinin tetrapeptide-induced panic symptoms in healthy volunteers.
    Bradwejn J; Koszycki D; Paradis M; Reece P; Hinton J; Sedman A
    Biol Psychiatry; 1995 Dec; 38(11):742-6. PubMed ID: 8580227
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cholecystokinin and panic disorder: past and future clinical research strategies.
    Bradwejn J; Koszycki D
    Scand J Clin Lab Invest Suppl; 2001; 234():19-27. PubMed ID: 11713976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anxiety modulation by the heart? Aerobic exercise and atrial natriuretic peptide.
    Ströhle A; Feller C; Strasburger CJ; Heinz A; Dimeo F
    Psychoneuroendocrinology; 2006 Oct; 31(9):1127-30. PubMed ID: 17010527
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The efficacy and tolerability of tiagabine in adult patients with post-traumatic stress disorder.
    Davidson JR; Brady K; Mellman TA; Stein MB; Pollack MH
    J Clin Psychopharmacol; 2007 Feb; 27(1):85-8. PubMed ID: 17224720
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CCK-4: Psychophysiological conditioning elicits features of spontaneous panic attacks.
    Hinkelmann K; Yassouridis A; Mass R; Tenge H; Kellner M; Jahn H; Wiedemann K; Wolf K
    J Psychiatr Res; 2010 Dec; 44(16):1148-53. PubMed ID: 20451215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of CCK-tetrapeptide in patients with social phobia and obsessive-compulsive disorder.
    Katzman MA; Koszycki D; Bradwejn J
    Depress Anxiety; 2004; 20(2):51-8. PubMed ID: 15390214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association testing of panic disorder candidate genes using CCK-4 challenge in healthy volunteers.
    Maron E; Tõru I; Tasa G; Must A; Toover E; Lang A; Vasar V; Shlik J
    Neurosci Lett; 2008 Dec; 446(2-3):88-92. PubMed ID: 18832011
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Associations between personality traits and CCK-4-induced panic attacks in healthy volunteers.
    Tõru I; Aluoja A; Võhma U; Raag M; Vasar V; Maron E; Shlik J
    Psychiatry Res; 2010 Jul; 178(2):342-7. PubMed ID: 20471107
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of BI 1358894 on Cholecystokinin-Tetrapeptide (CCK-4)-Induced Anxiety, Panic Symptoms, and Stress Biomarkers: A Phase I Randomized Trial in Healthy Males.
    Goettel M; Fuertig R; Mack SR; Just S; Sharma V; Wunder A; den Boer J
    CNS Drugs; 2023 Dec; 37(12):1099-1109. PubMed ID: 38019356
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tiagabine increases slow-wave sleep in a dose-dependent fashion without affecting traditional efficacy measures in adults with primary insomnia.
    Walsh JK; Perlis M; Rosenthal M; Krystal A; Jiang J; Roth T
    J Clin Sleep Med; 2006 Jan; 2(1):35-41. PubMed ID: 17557435
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Benzodiazepines counteract rostral anterior cingulate cortex activation induced by cholecystokinin-tetrapeptide in humans.
    Leicht G; Mulert C; Eser D; Sämann PG; Ertl M; Laenger A; Karch S; Pogarell O; Meindl T; Czisch M; Rupprecht R
    Biol Psychiatry; 2013 Feb; 73(4):337-44. PubMed ID: 23059050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased ACTH concentrations associated with cholecystokinin tetrapeptide-induced panic attacks in patients with panic disorder.
    Ströhle A; Holsboer F; Rupprecht R
    Neuropsychopharmacology; 2000 Mar; 22(3):251-6. PubMed ID: 10693152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tiagabine enhances slow wave sleep and sleep maintenance in primary insomnia.
    Walsh JK; Zammit G; Schweitzer PK; Ondrasik J; Roth T
    Sleep Med; 2006 Mar; 7(2):155-61. PubMed ID: 16260179
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tiagabine affects the subjective responses to cocaine in humans.
    Sofuoglu M; Poling J; Mitchell E; Kosten TR
    Pharmacol Biochem Behav; 2005 Nov; 82(3):569-73. PubMed ID: 16332385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tiagabine for the treatment of anxiety.
    Crane D
    Depress Anxiety; 2003; 18(1):51-2. PubMed ID: 12900953
    [No Abstract]   [Full Text] [Related]  

  • 38. Low-dose tiagabine effectiveness in anxiety disorders.
    Schaller JL; Thomas J; Rawlings D
    MedGenMed; 2004 Sep; 6(3):8. PubMed ID: 15520630
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of a metabotropic glutamate(2/3) receptor agonist (LY544344/LY354740) on panic anxiety induced by cholecystokinin tetrapeptide in healthy humans: preliminary results.
    Kellner M; Muhtz C; Stark K; Yassouridis A; Arlt J; Wiedemann K
    Psychopharmacology (Berl); 2005 Apr; 179(1):310-5. PubMed ID: 15821951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effect of 5-hydroxytryptophan on cholecystokinin-4-induced panic attacks in healthy volunteers.
    Maron E; Tõru I; Vasar V; Shlik J
    J Psychopharmacol; 2004 Jun; 18(2):194-9. PubMed ID: 15260907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.